{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Pao Pereira", "cancer stem-like cells", "pancreatic cancer", "xenograft models"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29985062", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "24"}, "DateRevised": {"Year": "2019", "Month": "04", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1177/1534735418786027"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "17", "Issue": "4", "PubDate": {"Year": "2018", "Month": "Dec"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo.", "Pagination": {"StartPage": "1204", "EndPage": "1215", "MedlinePgn": "1204-1215"}, "Abstract": {"AbstractText": ["Pancreatic cancers are enriched with cancer stem-like cells (CSCs), which are resistant to chemotherapies, and responsible for tumor metastasis and recurrence. Here, we investigated the extract of a medicinal plant Pao Pereira (Pao) for its activity against pancreatic CSCs. Pao inhibited overall proliferation of human pancreatic cancer cell lines with IC<sub>50</sub> ranging from 125 to 325 \u03bcg/mL and had limited cytotoxicity to normal epithelial cells. Pancreatic CSC population, identified using surface markers CD24+ CD44+ EpCam+ or tumor spheroid formation assay, was significantly reduced, with IC<sub>50</sub>s of ~100 \u03bcg/mL for 48 hours treatment, and ~27 \u03bcg/mL for long-term treatment. Nuclear \u03b2-catenin levels were decreased, suggesting suppression of Wnt/\u03b2-catenin signaling pathway. In vivo, Pao at 20 mg/kg, 5 times/week gavage, significantly reduced tumorigenicity of PANC-1 cells in immunocompromised mice, indicating inhibition of CSCs in vivo. Further investigation is warranted in using Pao as a novel treatment targeting pancreatic CSCs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Dong", "ForeName": "Ruochen", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Chen", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Chen", "ForeName": "Qi", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "CD24 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Epithelial Cell Adhesion Molecule"}, {"RegistryNumber": "0", "NameOfSubstance": "Hyaluronan Receptors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "beta Catenin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "CD24 Antigen"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Epithelial Cell Adhesion Molecule"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hyaluronan Receptors"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasm Recurrence, Local"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Pancreatic Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Wnt Signaling Pathway"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta Catenin"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the\nresearch, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.", "ArticleIdList": ["29313949"]}, {"Citation": "\nAmerican Cancer Society. Cancer facts and\nfigures\n2018. \nhttps://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf.\nAccessed February 22, 2018."}, {"Citation": "Fingerhut A, Vassiliu P, Dervinis C, Alexakis N, Leandros E. What is in a word: pancreatoduodenectomy or pancreaticoduodenectomy? Surgery. 2007;142:428-429.", "ArticleIdList": ["17723902"]}, {"Citation": "Yu Y, Ramena G, Elble RC. The role of cancer stem cells in relapse of solid tumors. Front Biosci (Elite Ed). 2012;4:1528-1541.", "ArticleIdList": ["22201973"]}, {"Citation": "Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605-1617.", "ArticleIdList": ["20427809"]}, {"Citation": "Oettle H, Neuhaus P. Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs. 2007;67:2293-2310.", "ArticleIdList": ["17983252"]}, {"Citation": "Renouf D, Moore M. Evolution of systemic therapy for advanced pancreatic cancer. Expert Rev Anticancer Ther. 2010;10:529-540.", "ArticleIdList": ["20397918"]}, {"Citation": "Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691-1703.", "ArticleIdList": ["PMC4631139", "24131140"]}, {"Citation": "Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M. The role of the FOLFIRINOX regimen for advanced pancreatic cancer. Curr Oncol Rep. 2013;15:182-189.", "ArticleIdList": ["23341367"]}, {"Citation": "Faris JE, Blaszkowsky LS, McDermott S, et al. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist. 2013;18:543-548.", "ArticleIdList": ["PMC3662845", "23657686"]}, {"Citation": "Vishnu P, Roy V. Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer. Breast Cancer (Auckl). 2011;5:53-65.", "ArticleIdList": ["PMC3091407", "21603258"]}, {"Citation": "Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817-1825.", "ArticleIdList": ["21561347"]}, {"Citation": "Schmied BM, Ulrich A, Matsuzaki H, Li CH, Pour PM. In vitro pancreatic carcinogenesis. Ann Oncol. 1999;10(suppl 4):41-45.", "ArticleIdList": ["10436783"]}, {"Citation": "Du Z, Qin R, Wei Z, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in \u201cstem-cell-like\u201d tumor cells. Dig Dis Sci. 2011;56:741-750.", "ArticleIdList": ["20683663"]}, {"Citation": "Lonardo E, Cioffi M, Sancho P, Crusz S, Heeschen C. Studying pancreatic cancer stem cell characteristics for developing new treatment strategies. J Vis Exp. 2015;(100):e52801.", "ArticleIdList": ["PMC4544916", "26132091"]}, {"Citation": "Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.", "ArticleIdList": ["11689955"]}, {"Citation": "Ajani JA, Song S, Hochster HS, Steinberg IB. Cancer stem cells: the promise and the potential. Semin Oncol. 2015;42(suppl 1):S3-S17.", "ArticleIdList": ["25839664"]}, {"Citation": "Vinogradov S, Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond). 2012;7:597-615.", "ArticleIdList": ["PMC3376090", "22471722"]}, {"Citation": "Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Cancer stem cells and their role in metastasis. Pharmacol Ther. 2013;138:285-293.", "ArticleIdList": ["PMC3602306", "23384596"]}, {"Citation": "Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. Beta-carboline alkaloid-enriched extract from the amazonian rain forest tree pao pereira suppresses prostate cancer cells. J Soc Integr Oncol. 2009;7:59-65.", "ArticleIdList": ["PMC6358020", "19476740"]}, {"Citation": "Steele JC, Veitch NC, Kite GC, Simmonds MS, Warhurst DC. Indole and beta-carboline alkaloids from Geissospermum sericeum. J Nat Prod. 2002;65:85-88.", "ArticleIdList": ["11809075"]}, {"Citation": "Mbeunkui F, Grace MH, Lategan C, Smith PJ, Raskin I, Lila MA. In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii. J Ethnopharmacol. 2012;139:471-477.", "ArticleIdList": ["22143154"]}, {"Citation": "Reina M, Ruiz-Mesia W, L\u00f3pez-Rodr\u00edguez M, Ruiz-Mesia L, Gonz\u00e1lez-Coloma A, Mart\u00ednez-D\u00edaz R. Indole alkaloids from Geissospermum reticulatum. J Nat Prod. 2012;75:928-934.", "ArticleIdList": ["22551062"]}, {"Citation": "Yu J, Chen Q. The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer. Pharm Biol. 2014;52:36-43.", "ArticleIdList": ["24033267"]}, {"Citation": "Yu J, Drisko J, Chen Q. Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao pereira. Oncol Rep. 2013;30:149-156.", "ArticleIdList": ["23674070"]}, {"Citation": "Chang C, Zhao W, Xie B, et al. Pao pereira extract suppresses castration-resistant prostate cancer cell growth, survival, and invasion through inhibition of NF\u03baB signaling. Integr Cancer Ther. 2014;13:249-258.", "ArticleIdList": ["24287876"]}, {"Citation": "Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014;47:1-11.", "ArticleIdList": ["PMC3968261", "24693477"]}, {"Citation": "Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A. 2008;105:13427-13432.", "ArticleIdList": ["PMC2533206", "18765800"]}, {"Citation": "Kim SY, Hong SH, Basse PH, et al. Cancer stem cells protect non-stem cells from anoikis: bystander effects. J Cell Biochem. 2016;117:2289-2301.", "ArticleIdList": ["26918647"]}, {"Citation": "Goodell MA, S. McKinney-Freeman S, Camargo FD. Isolation and characterization of side population cells. Methods Mol Biol. 2005;290:343-352.", "ArticleIdList": ["15361673"]}, {"Citation": "Richard V, Nair MG, Kumar TRS, Pillai MR. Side population cells as prototype of chemoresistant, tumor-initiating cells. Biomed Res Int. 2013;2013:517237.", "ArticleIdList": ["PMC3834974", "24294611"]}, {"Citation": "Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol. 2009;568:161-173.", "ArticleIdList": ["19582426"]}, {"Citation": "Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97-106.", "ArticleIdList": ["21151206"]}, {"Citation": "MacDonald BT, Tamai K, He X. Wnt/\u03b2-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26.", "ArticleIdList": ["PMC2861485", "19619488"]}, {"Citation": "Cheng P, Sun X, Yin D, et al. Nanog down-regulates the Wnt signaling pathway via \u03b2-catenin phosphorylation during epidermal stem cell proliferation and differentiation. Cell Biosci. 2015;5:5.", "ArticleIdList": ["PMC4429823", "25973172"]}, {"Citation": "Yong X, Tang B, Xiao YF, et al. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/\u03b2-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016;374:292-303.", "ArticleIdList": ["26940070"]}, {"Citation": "Takao Y, Yokota T, Koide K. Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonicstem cells. Biochem Biophys Res Commun. 2007;353:699-705.", "ArticleIdList": ["17196549"]}, {"Citation": "An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol. 2009;5:1529-1542.", "ArticleIdList": ["19708828"]}, {"Citation": "Salmaggi A, Boiardi A, Gelati M, et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia. 2006;54:850-860.", "ArticleIdList": ["16981197"]}, {"Citation": "Nagare RP, Sneha S, Priya SK, Ganesan TS. Cancer stem cells\u2014are surface markers alone sufficient? Curr Stem Cell Res Ther. 2017;12:37-44.", "ArticleIdList": ["27280437"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29985062", "PMC6247539", "10.1177/1534735418786027"]}}]}